“Catalpol Alleviates the Lipopolysaccharide-Induced Inflammatory Response of BV2 Cells”. 2024. Bangladesh Journal of Pharmacology 19 (3): 88-94. https://doi.org/10.3329/bjp.v19i3.76556.